Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Thyroid Hormone and Estrogen Regulate Exercise-Induced Growth Hormone Release

  • Daniele Leão Ignacio,

    Affiliation Institute of Biophysics Carlos Chagas Filho and School of Physical Education and Sports, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

  • Diego H. da S. Silvestre,

    Affiliation Institute of Biophysics Carlos Chagas Filho and School of Physical Education and Sports, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

  • João Paulo Albuquerque Cavalcanti-de-Albuquerque,

    Affiliation Institute of Biophysics Carlos Chagas Filho and School of Physical Education and Sports, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

  • Ruy Andrade Louzada,

    Affiliation Institute of Biophysics Carlos Chagas Filho and School of Physical Education and Sports, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

  • Denise P. Carvalho ,

    Contributed equally to this work with: Denise P. Carvalho, João Pedro Werneck-de-Castro

    Affiliation Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

  • João Pedro Werneck-de-Castro

    Contributed equally to this work with: Denise P. Carvalho, João Pedro Werneck-de-Castro

    Affiliations Institute of Biophysics Carlos Chagas Filho and School of Physical Education and Sports, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, Department of Endocrinology and Metabolism, Rush University Medical Center, Chicago, Illinois, United States of America

Thyroid Hormone and Estrogen Regulate Exercise-Induced Growth Hormone Release

  • Daniele Leão Ignacio, 
  • Diego H. da S. Silvestre, 
  • João Paulo Albuquerque Cavalcanti-de-Albuquerque, 
  • Ruy Andrade Louzada, 
  • Denise P. Carvalho, 
  • João Pedro Werneck-de-Castro


Growth hormone (GH) regulates whole body metabolism, and physical exercise is the most potent stimulus to induce its secretion in humans. The mechanisms underlying GH secretion after exercise remain to be defined. The aim of this study was to elucidate the role of estrogen and pituitary type 1 deiodinase (D1) activation on exercise-induced GH secretion. Ten days after bilateral ovariectomy, animals were submitted to 20 min of treadmill exercise at 75% of maximum aerobic capacity and tissues were harvested immediately or 30 min after exercise. Non-exercised animals were used as controls. A significant increase in D1 activity occurred immediately after exercise (~60%) in sham-operated animals and GH was higher (~6-fold) 30 min after exercise. Estrogen deficient rats exhibited basal levels of GH and D1 activity comparable to those found in control rats. However, after exercise both D1 activity and serum GH levels were blunted compared to sedentary rats. To understand the potential cause-effect of D1 activation in exercise-induced GH release, we pharmacologically blocked D1 activity by propylthiouracil (PTU) injection into intact rats and submitted them to the acute exercise session. D1 inhibition blocked exercise-induced GH secretion, although basal levels were unaltered. In conclusion, estrogen deficiency impairs the induction of thyroid hormone activating enzyme D1 in the pituitary, and GH release by acute exercise. Also, acute D1 activation is essential for exercise-induced GH response.


Overweight and obesity are epidemic diseases leading to diabetes and metabolic syndromes, and are associated with cardiovascular disorders [1], especially for women facing the menopause transition [2]. Fluctuations in sex hormones at different stages of reproductive life, such as menarche, pregnancy, and menopause transition, may play a role in the adipose tissue expansion. Notably, menopausal transition is associated with unfavorable changes in body composition, abdominal fat deposition and general health outcomes [35]. Thus, understanding the mechanism involved in the genesis of obesity during the menopausal transition will help the development of strategies to fight obesity [4].

Growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis regulates growth and development during childhood and adolescence, but also regulates body composition, metabolism and exercise aerobic capacity throughout life [5]. Increased lipolysis and free fat acids (FFA) mobilization are the main effect of GH in metabolism [6]; e.g. the most prominent effect of physiological GH pulse exposure is a marked stimulation of lipolysis [79]. Its deficiency (GHD) is associated with increased body fat and a lower lean body mass [10, 11]. These changes in body composition are associated with metabolic derangements including insulin resistance [9].

Besides GH, estrogen (E2) and thyroid hormones (TH) control energy expenditure and are essential for body weight balance [12]. Active thyroid hormone T3 acts virtually in all body tissues trough interaction with nuclear receptors. In addition to serum T3, local availability and clearance are well controlled by types I, II, and III iodothyronine deiodinases (D1, D2, and D3, respectively) via removal of specific iodine atoms from the precursor molecule T4 or T3 itself. D1 and D2 catalyze the 5'-deiodination of T4 and therefore they are considered activating enzymes due to subsequent T3 production. On the other hand, D3 inactivates T4 and T3 through their 5-deiodination [13,14]. Thus, modulation of deiodinases expression and activity customize T3 biological effects. Moreover there is an interplay by E2 and TH in several biological effects, for example, the lack of E2 in rats leads to obesity and decreases D2 activity in brown adipose fat in a long-term ovariectomy protocol (9 weeks) [11].

Multiple physiological factors modulate GH secretion, such as age, estrogen, nutrition, sleep, body composition, regional distribution of body fat, stress, insulin, fitness, TH and physical exercise [12]. Among them acute aerobic exercise is the most potent stimulus to GH release [1519]. Indeed, after exercise GH levels increase 5.1-fold in humans [18] and GH secretion is correlated to exercise intensity [15,19]. Proposed mechanisms for such increase are: acidosis [20]; central adrenergic outflow [21], core body temperature [22] and cholinergic mediation [23]. Interestingly, obese patients present a blunted spontaneous GH secretion as well as in response to exercise attributed to a decrease in pulsatile GH release and a shorter half-life of endogenous GH [24]. Many obesity-related physical adaptations resemble those recognized in GH-deficient adults [16] and menopause [4], including reduced muscle mass and exercise capacity, increased body fat especially abdominal visceral fat (AVF), and increased cardiometabolic risk [16] suggesting the involvement of these hormones in the genesis of obesity.

GH is a major T3-induced protein in the rat pituitary [25] and T3 regulates GH gene in transcriptional and posttranscriptional level [26, 27]. Somatotrophs highly express D1 and are the major cell population of pituitary [25, 28]. Pituitary (PIT) D1 [28] and brown adipose tissue (BAT) D2 [11] activities increase after a single running exercise session [28], and in response to a 8-week swimming exercise training program [11]. In the later study, both PIT D1 and BAT D2 activities response to exercise are blunted in trained obese estrogen deficient rats [11]. Taken together, these results suggest that impairment of T4-to-T3 conversion in PIT and BAT by decreased D1 and D2 activities respectively in response to exercise could be involved in the genesis of obesity in E2 deficient rats trough (i) decreasing GH release by PIT and/or (ii) reducing BAT metabolism. Here we report that low levels of E2 prejudice PIT D1 activation and GH release after acute high intensity treadmill exercise before the onset of obesity (short term ovariectomy). In addition, pharmacological blockage of D1 also decreases exercise-induced GH release linking thyroid hormone signaling to GH release after exercise.

Materials and Methods

Animals and experimental groups

Adult female Wistar rats weighing 200–250 g donated by the Vital Brazil Institute (Niteroi, 113 RJ—Brazil) were kept in a temperature-controlled (22±1°C) animal room, with a 12 h light-dark cycle (lights on at 6 pm), and pelleted commercial chow (Paulínea, São Paulo, Brazil; iodine content 2 mg/kg) and water were available ad libitum. All adult female rats showed a regular 4–5 day estrous cycle monitored by vaginal cytology collected each morning for 2 consecutive weeks before starting the experiments. The Rio de Janeiro Federal University Institutional Committee for Animal Use in Research (CEUA—CCS—EEFD 05) approved this study, which was in accordance with the International Guiding Principles for Biomedical Research Involving Animals (Geneva, Switzerland).

Ovariectomy and exercise protocol

The surgery consisted of bilateral removal of ovaries under anesthesia with ketamine (50 mg/kg, i. p.) and xylazine (5 mg/kg, i. p.) as describe previously [11] and all efforts were made to minimize suffering. Sham (Sh) animals were submitted to the surgical procedure except to ovaries removal. The animals were used after 10 days of ovariectomy in order to prevent changes in body composition that occurs later on.

All animals were submitted to an exercise protocol consisted of 20 min treadmill running at 70–75% of maximum speed Smax under a constant slope of 10°. To determine Smax, the animals were adapted to run 2–3 days at 17 cm/s during 5 min. After adaptation period, each rat was submitted to a maximal exercise test, as previously described [28]. Trial began at a starting velocity of 17 cm/s and a constant slope of 10°. Treadmill velocity was then increased by 2 cm/s every 2 min and the rats ran until exhaustion (when the animals stayed in the steel grids despite increasing shocks stimuli). Smax was considered if animals completed at least 75% of the stage. Mean room temperature was maintained at 22°C and a stainless steel grid at the end of the treadmill provided an electrical stimulus to keep the rats running. All tests and exercise protocol were carried out with a motor-driven treadmill chamber (Panlab—LSI Letica model). Smax correspond to speed at maximal oxygen consumption [29].

Animals were not fed after the exercise session and were killed by decapitation and blood was collected for hormone concentration analyses. Serum was obtained after centrifugation of the blood at 1500 x g for 20 min and stored at -80°C. Pituitary were dissected out and stored at -80°C until processing for enzymatic measurements. Retroperitoneal and inguinal fat pads were completely removed, weighted for evaluation of adiposity and discarded.

Body composition

Body composition was evaluated by dual-energy X-ray absorptiometry. Before submitted to DXA, animals were anesthetized with ketamine (50 mg/kg, i. p.) and xylazine (5 mg/kg, i. p.) as describe previously [11]. Lunar DXA 200368 GE instrument (Lunar, Wisconsin, USA) with specific software (encore 2008, version 12.20 GE Healthcare) was used to measure: Body weight (g), body fat mass (g), lean body mass (g), bone mineral density (g/cm2), fat free mass (g), visceral fat (%) and total body fat (%).

Serum hormone measurements

Serum estradiol levels were measured by specific RIA (MP Biomedicals, LLC, USA). The intra-assay variation coefficient was 3.5–15.7%. The inter-assay variation coefficient was 5.5–15.4%. Radioactivity was counted in an automatic gamma counter (1470 Wallac WizardTM automatic gammacounter). Limit of detection was 10–3 000 pg/ml. The results were expressed in pg/ml. All the procedures were carried out following the recommendations of the kits.

Serum total GH (ng/ml) was measured by either specific radioimmunoassay (RIA—Lincon Research) or ELISA (Mediagnost, Tuebingen, Germany), as stated in figure legends. All immune assays were performed according to manufacturer’s instructions. Limit of detection was 0.5–50 ng/ml for RIA and 0.025–1.5 ng/ml for ELISA. The intra- and inter-assay coefficient of variation was 3.5–15.7% and 5.5–15.4%, respectively (limits of detection 10–3000 pg/ml. Radioactivity was counted in an automatic gamma counter (1470 Wallac WizardTM automatic gamma counter).

Type 1 iodothyronine deiodinase (D1) activity

Pituitary gland was homogenized in 0.1 M sodium phosphate buffer containing 1 mM EDTA, 0.25 M sucrose, and 10 mM dithiothreitol (pH 6.9). Protein concentration was measured by the Bradford method [30]. Homogenates (20 μg of protein) were incubated for 1 h at 37°C with 1 μM rT3 (Sigma, USA) containing freshly purified (Sephadex LH20) tracer (100.000 cpm [125I] rT3, PerkinElmer Life Sciences, Boston, MA, USA) and 10 mM dithiothreitol in 100 mM PBS containing 1 mM EDTA (pH 6.9), as previously described [31]. Blank incubations were carried out in the absence of protein. The reaction was stopped on ice followed by immediate addition of 200 μl fetal bovine serum (Cultilab, BR) and 100 μl trichloroacetic acid (50%, v/v). The specific enzymatic activity was expressed as picomoles of rT3 deiodinated/min/mg protein.

PTU treatment

Propylthiouracil (PTU) acutely inhibits D1 activity [31]. 100 μl of PTU (ip; 2 mg of PTU/100g bw) was injected 4 h and 5 min before the acute exercise session into intact animals. The control group received 100 μl of saline.


The results are expressed as mean ± SEM and p < 0.05 was considered statistically significant. GH secretion in intact animals was analyzed by one-way ANOVA followed by Dunnett’s Multiple Comparison test. GH secretion in ovariectomized rats and D1 activity were analyzed by two-way ANOVA followed by Bonferroni multiple comparison test. Serum levels of estradiol, GH after D1 inhibition body and fat mass were analyzed by unpaired t-test.


Short-term ovariectomy (Ovx) decreases E2 levels but does not induce obesity

Ovx is a well-recognized model to study estrogen deficiency in rodents [11, 32, 33] and E2 deficient rats gain weigh after 9–14 d of Ovx [33] and develop obesity [11,32]. We studied rats submitted to a short-term Ovx (10 d) to avoid the impact of obesity on GH secretion [16,24]. Indeed, Ovx rats exhibited lower levels of estradiol (33%) compared to intact rats, but the body weight was not different (Table 1). Moreover, short-term Ovx did not modify body composition (Table 1). In order to rule out the effects of Ovx on exercise capacity we tested the groups before and after Ovx. Ovx rats ran as much as control animals and reached comparable levels of maximal speed and blood lactate levels (Table 2). All animals were able to complete the acute exercise session. The speed (75% Smax) employed in acute exercise was similar between groups as well as the blood lactate increment (Table 3).

Table 1. Effects of 10 days of ovariectomy on hormone concentration and body composition.

Table 2. Effects of 10d of ovariectomy (Ovx) on maximal aerobic capacity and blood lactate concentration.

High intensity exercise induces GH secretion

In humans, after acute high intensity exercise growth hormone increases in blood and continues to increase during the following recovery minutes [34]. In rats, only one study investigated GH response to acute exercise [35]. Thus, we first performed a time course of GH release in our model of high intensity treadmill exercise. Immediately after exercise, serum GH levels decreased (~74%) although not statistically significant (Fig 1). Twenty minutes after exercise, serum GH increased 2-fold and peaked at 30 min (~2.4-fold) (Fig 1). For that reason, subsequent studies were performed at 30 minutes.

Fig 1. Post-exercise growth hormone secretion.

Values are mean ± SEM (n = 10). *p<0.05 vs basal (non-exercised group) analyzed by one-way analysis of variance followed by the Dunnett’s multiple comparison test.

Estrogen deficiency impairs acutely exercise-induced pituitary D1 activation and GH release

Both D1 and D2 activate thyroid hormones by converting T4-to-T3 locally [13]. PIT D1 activity is greater in exercised rats but not D2 [28], strongly suggesting a role played by D1 in PIT function after exercise. Thus, we tested whether Ovx could impair D1 activation in PIT after acute exercise, as reported by our group after 8 weeks of swimming exercise training [11]. A significant increase in D1 activity occurred immediately after exercise (~60%; Fig 2A) in sham-operated animals and GH was higher (~6-fold; Fig 2B) 30 min after exercise. Estrogen deficient rats exhibited comparable basal levels of GH and D1 activity. However, after exercise both D1 activity and serum GH levels were blunted in Ovx compared to sedentary rats (Fig 2A and 2B).

Fig 2. Effects of high intensity treadmill exercise on pituitary D1 activity and GH release.

A) Pituitary type 1 deiodinase activity in Sham and Ovx groups before (basal) and after exercise (30 min) and B) Serum levels of growth hormone before (basal) and after exercise (30 min). Values are mean ± SEM. Sample size is shown in parenthesis. *p<0.05 and ** p<0.01 analyzed by two-way ANOVA followed by the Bonferroni multiple comparison test.

Inhibition of D1 activity decreases exercise-induced GH release

The fact that E2 impairs D1 and GH response to exercise suggest that D1 could be important to GH release after exercise. Thus, it is conceivable to hypothesize that inhibition of D1 could blunt GH response to exercise. To test this, intact rats were treated with PTU, a pharmacological blocker of D1 activity [31] before submitted to the exercise protocol. Remarkably, PTU abolished GH appearance in blood 30 min after exercise (Fig 3), suggesting that pituitary D1 activation is important for local T3 production and GH release after exercise.

Fig 3. Impact of D1 inhibition by PTU on circulating levels of growth hormones.

Values are mean ± SEM. Sample size is shown in parenthesis. *p<0.05 analyzed by two-way ANOVA followed by the Bonferroni multiple comparison test.


The present study reveals that estrogen deficiency caused by short-term ovariectomy (Ovx) blunts growth hormone (GH) release induced by high intensity exercise (Fig 2B), as well as thyroid hormone activating enzyme D1 activity in pituitary (Fig 2A). In this model, female rats are not obese yet (Table 1) and exercise capacity is preserved (Table 2) which allows us to study the early events of Ovx before obesity is installed, since overweight impacts GH response to exercise [23]. These set of experiments suggest that T4-to-T3 conversion in PIT could play a role in GH release after exercise. Indeed, pharmacological blockage of D1 abolished GH induction in our model of high intensity treadmill exercise in female rats (Fig 3).

Few studies investigated GH secretion using physical exercise stimulus in rats [12,35]. Therefore, we first determined the time course of GH secretion after high intensity treadmill exercise in female rats (Fig 1). Although not significant, exercise seems to suppress GH release right after exercise (time 0 in Fig 1; q = 1.648) to ~26% of basal levels. Thereafter, as in humans [15], GH increased with time reaching a peak at 30 minutes after exercise (Fig 1). Butkus et al [35] studying female Sprague-Dawley rats reported that GH release decreased during the acute treadmill exercise bout and typical GH pulses did not recover up to 5.5 hours post-exercise. Their exercise protocol did not increase lactate levels [35]. The rat strain used and the exercise intensity could explain the contrasting results. In our study, we set the intensity (75%) relative to maximum aerobic capacity (maximal speed—Smax) to reproduce studies performed in humans [15] and this intensity increased lactate levels in blood more than 3-fold (77–88% of maximal lactate response in average) confirming the high intensity nature of our exercise protocol. Also, we previously showed that 75% Smax in male Wistar rats represented 88% of maximal oxygen consumption which characterizes a high intensity exercise. In humans, the linear dose-response relationship between exercise intensity and the GH response is well stablished [19]. Felsing et al [15] studying the effects of the exercise intensity on GH circulating levels in men reported greater serum GH and insulin concentrations 20–30 min after the highest exercise intensity. Therefore, our exercise protocol is a potent stimulus to induce GH appearance in blood, as occurs in humans.

Many factors modulate GH secretion such as physical exercise, fat mass and gonadal steroids [12]. Basal levels of GH are diminished in obesity as well as GH response to exercise [36]. Reduction in the quantity of GH secreted per pulse is the primary mechanism responsible for the lower serum GH concentrations after exercise in obese compared to lean women [24]. The lack of ovarian hormones in female adult rats leads to a significant increase in body mass [11] between 9–13 days after Ovx and the effects are reverted by Estrogen (E2) treatment [32,33]. To avoid the influence of obesity-induced impairment of GH secretion we did the short-term ovariectomy protocol (10 d), when Ovx rats were not obese yet (Table 1) although serum E2 levels were 33% reduced (Table 1). In our model, GH secretion after 30 minutes of exercise was lower in ovariectomized rats compared to sham, suggesting that estradiol is important to exercise-induced GH release (Fig 2B). It is already known that E2 regulates GH axis [3638]. Our results add new insight in GH modulation under a stressful condition as intense physical exercise.

Thyroid hormone (TH) remarkably modulates GH secretion [12,14,25]. Tissue concentration of T3, the biologically active TH, and saturation of its nuclear receptors rely on transmembrane transport from blood to cytoplasm and the locally conversion of T4 to T3 by deiodinases [14]. Both D1 and D2 activate TH in pituitary, and 50% of PIT is comprised by GH-secreting cells. We previously demonstrated that both acute and chronic exercise positively modulate D1 activity in PIT, potentially linking T4-to-T3 conversion to GH release. [11,28]. Swimming training during 8 weeks increased D1 activity in sham-trained female rats, while gonadectomy blunted the exercise training effect [11]. A time-course study in male rats using the same acute exercise model reported that PIT D1 activity increased 30, 60, and 120 min after exercise compared to sedentary control animals [28]. In the present study we confirmed that D1 activity is induced by acute exercise at 30 min in female rats, however, after 60 min the activity returned to basal levels (Fig 2A). The reason for this sexual dimorphism is unclear. More importantly, the lack of E2 blunts D1 response after exercise suggesting that E2 is critical to T3 production through D1 activation in PIT. Together, the evidence that Ovx impairs both GH release and PIT D1 activity induction led us to investigate the role of D1 in exercise-induced GH release. Notably, inhibition of D1 by PTU injection abolished GH response (Fig 3).

In conclusion, estrogen deficiency impairs the induction of thyroid hormone activating enzyme D1 in the pituitary and GH release by acute exercise. Also, pituitary D1 activation is essential for exercise-induced GH response.


The study was supported by research grants from CNPq, FAPERJ and CAPES. Daniele Leão Ignacio is recipient of a fellowship from CAPES. The authors are grateful to prof. Andrea Claudia Ferreira from UFRJ for technical support on GH measurements and to prof. Patricia Lisboa from UERJ for DXA assessment.

Author Contributions

Conceived and designed the experiments: DLI DPC JPWC. Performed the experiments: DLI DHSS RAL JPAC. Analyzed the data: DLI DHSS RAL JPAC DPC JPWC. Contributed reagents/materials/analysis tools: DPC JPWC. Wrote the paper: DLI JPWC.


  1. 1. Ippoliti F, Canitano N, Businaro R (2013) Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective. J Neuroimmune Pharmacol 8:212–26. pmid:23329173
  2. 2. Nappi RE, Kokot-Kierepa M (2012) Vaginal Health: Insights, Views & Attitudes (VIVA)—results from an international survey. Climacteric 15:36–44. pmid:22168244
  3. 3. Poehlman ET (2002) Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 84:1131.
  4. 4. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi ME, Shah D, et al. (2012) Understanding weight gain at menopause. Climacteric 15:419–29. pmid:22978257
  5. 5. Fanciulli G, Delitala A, Delitala G (2009) Growth hormone, menopause and ageing: no definite evidence for “rejuvenation” with growth hormone. Hum Reprod Update 15:341–58. pmid:19228699
  6. 6. Jørgensen JOL, Rubeck KZ, Nielsen TS, Clasen BFF, Vendelboe M, Hafstrøm TK, et al. (2010) Effects of GH in human muscle and fat. Pediatr Nephrol 25:705–9. pmid:19902270
  7. 7. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thamason M, Ampleby AM, et al. (1993) The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 38:427–31. pmid:8319375
  8. 8. Snel YE, Brummer RJ, Doerga ME, Zellisen PM, Bakker CJ, Hendriks MJ, et al. (1995) Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. Am J Clin Nutr 61:1290–4. pmid:7762533
  9. 9. Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G. (2010) GH/IGF-I regulation in obesity—mechanisms and practical consequences in children and adults. Horm Res pædiatrics 73:153–60.
  10. 10. Rogers NH, Perfield JW, Strissel KJ, Obin MS, Greenberg AS. (2009) Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150:2161–8. pmid:19179442
  11. 11. Ignacio DL, Fortunato RS, Neto RAL, da Silva Silvestre DH, Nigro M. (2012) Blunted response of pituitary type 1 and brown adipose tissue type 2 deiodinases to swimming training in ovariectomized rats. Horm Metab Res 44:797–803. pmid:22815055
  12. 12. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–97. pmid:9861545
  13. 13. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, et al. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29:898–938. pmid:18815314
  14. 14. Bianco AC, Salvatore D, Gereben B, Berry MA, Larsen PR (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38–89. pmid:11844744
  15. 15. Felsing NE, Anne JO, Cooper M, Street WC (1992) Effect of Low and High Intensity Exercise on circulating growth hormone in men. JCEM 75:157–162. pmid:1619005
  16. 16. Weltman A, Weltman JY, Watson Winfield DD, Frick K, Patrie J, Kok P, et al. (2008) Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion. J Clin Endocrinol Metab 93:4711–20. pmid:18782875
  17. 17. Wideman L, Consitt L, Patrie J, Swearingin B, Bloomer R, Davis P, et al. (2006) The impact of sex and exercise duration on growth hormone secretion. J Applyed Physiol 27402:1641–1647.
  18. 18. . Wideman L, Weltman JY, Shah N, Story S, Veldhuis JD, Weltman A, et al. (1999) Effects of gender on exercise-induced growth hormone release. J Appl Physiol 87:1154–62. pmid:10484590
  19. 19. Pritzlaff-Roy CJ, Widemen L, Weltman JY, Abbot R, Gutgesell M, Hartman ML, et al. (2002) Gender governs the relationship between exercise intensity and growth hormone release in young adults. J Appl Physiol 92:2053–60. pmid:11960957
  20. 20. Gordon SE, Kraemer WJ, Vos NH, Lynch JM, Knuttgen HG (1994) Effect of acid-base balance on the growth hormone response to acute high-intensity cycle exercise. J Appl Physiol 76:821–9. pmid:8175595
  21. 21. Weltman A., Weltman JY, Womack CJ, Davis SE, Blumer JL, Gaesser GA. (1997) Exercise training decreases the growth hormone (GH) response to acute constant-load exercise. Medicine and Science in Sports and Exercise, 29: 669–76. pmid:9140905
  22. 22. Wheldon A, Savine RL, Sönksen PH, Holt RIG (2006) Exercising in the cold inhibits growth hormone secretion by reducing the rise in core body temperature. Growth Horm IGF Res 16:125–31. pmid:16644256
  23. 23. Brillon D, Nabil L, Jacobs LS (1986) Cholinergic but not serotonergic mediation of exercise-induced growth hormone secretion. Endocr Res 12:137–46. pmid:3015580
  24. 24. Kanaley J a, Weatherup-Dentes MM, Jaynes EB, Hartman ML (1999) Obesity attenuates the growth hormone response to exercise. J Clin Endocrinol Metab 84:3156–61. pmid:10487680
  25. 25. Hervas F, Morreale de Escobar G, Escobar Del Rey F (1975) Rapid effects of single small doses of L-thyroxine and triiodo-L-thyronine on growth hormone, as studied in the rat by radioimmunoassy. Endocrinology 97:91–101. pmid:49266
  26. 26. Baur A, Köhrle J (1999) Type 1 deiodinase is stimulated by iodothyronines and involved in thyroid hormone metabolism in human somatomammotroph GX cells. Eur J Endocrinol 140:367–70. pmid:10097258
  27. 27. Ko J, Forschergruppe K, Poliklinik DM (1997) Reaggregate Cultures and GH3 Cells in Vitro *. 138:3242–3248. pmid:9231774
  28. 28. Fortunato RS, Ignacio DL, Padron AS, Peçanha R, Marassi MP, Rosenthal D, et al. (2008) The effect of acute exercise session on thyroid hormone economy in rats. J Endocrinol 198:347–53. pmid:18539729
  29. 29. Werneck-de-Castro JPS, Costa-e-Sousa RH, de Oliveira PF, Pinho-Ribeiro V, Mello DB (2006) G-CSF does not improve systolic function in a rat model of acute myocardial infarction. Basic Res Cardiol 101:494–501. pmid:16783485
  30. 30. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54. pmid:942051
  31. 31. Moreno M, Lombardi A, Beneduce L, Silvestri E, Pinna G, Goglia F, et al. (2002) Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself? Endocrinology 143:504–10. pmid:11796504
  32. 32. Cavalcanti-de-Albuquerque JP A, Salvador IC, Martins EL, Jardim Messeder D, Werneck-de-Castro JPS, Galina A, et al. (2014) Role of estrogen on skeletal muscle mitochondrial function in ovariectomized rats: a time course study in different fiber types. J Appl Physiol 116:779–89. pmid:24458744
  33. 33. Percegoni N, Ferreira ACF, Rodrigues CF, Rosenthal D, Castelo Branco MTL, Rumjanek VM, et al. (2009) Profile of serum IL-1beta and IL-10 shortly after ovariectomy and estradiol replacement in rats. Horm Metab Res 41:50–4. pmid:18841529
  34. 34. Kanaley J a, Weltman JY, Pieper KS, Weltman A, Hartman ML (2001) Cortisol and growth hormone responses to exercise at different times of day. J Clin Endocrinol Metab 86:2881–9. pmid:11397904
  35. 35. Butkus J, Brogan RS, Giustina A, Kastello G, Sothmann M, Wehrenberg B (1995) Changes in the Growth Hormone Axis Due to Exercise Training. Endocrinology 136:2664–2670. pmid:7750490
  36. 36. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, et al. (1995) Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209–22. pmid:7593428
  37. 37. Birzniece V, Sutanto S, Ho KKY (2012) Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J Clin Endocrinol Metab 97:E521–7. pmid:22319035
  38. 38. Veldhuis JD, Metzger DL, Martha PM, Mauras N, Kerrigan JR et al. (1997) Estrogen and Testosterone, But Not a Nonaromatizable Androgen, Direct Network Integration of the Like Growth Factor I Axis in the Human: Evidence from Pubertal Pathophysiology and Sex-Steroid Hormone Replacement. JCEM 82:3414–3420. pmid:9329378